Community health education for COVID-19 detection and vaccination in Hong Kong
A Multicenter, Cluster-Randomized, Active-Controlled, Single-Blind Trial of Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents
This study is trying to see if community health education can help people in Hong Kong get tested for COVID-19 more often, accept vaccinations, and adopt better self-protective measures.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1200 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Hung Hom) |
| Trial ID | NCT05539482 on ClinicalTrials.gov |
What this trial studies
This program aims to enhance early COVID-19 testing, increase vaccination acceptance, and improve self-protective measures among Hong Kong residents through community-based health education. It employs a Community-based Participatory Research (CBPR) approach, partnering with local stakeholders to recruit participants and implement educational initiatives. The program will involve half of the community collaborators receiving a core intervention package for education, while the other half will focus on health information sharing. This flexible and sustainable approach is designed to effectively mitigate COVID-19 risks in the community.
Who should consider this trial
Good fit: Ideal candidates include Hong Kong residents aged 18 and above, as well as students aged 12 to 18 and their parents.
Not a fit: Patients with cognitive impairments that prevent effective communication or those unwilling to provide consent may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve COVID-19 detection and vaccination rates, leading to better public health outcomes.
How similar studies have performed: Other community-based health education initiatives have shown success in improving public health outcomes, suggesting this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
For participants recruited by NGOs and companies, the Inclusion Criteria will be: * HK resident aged 18 years or above; * Agreement to participate in the study and provide written informed consent. The Exclusion Criteria will be: * Cognitive impairment that inhibits communication with the investigators; * Inability or unwillingness to provide written informed consent. For participants recruited by schools, the Inclusion Criteria will be: * HK students aged 12 to 18 years and their parents. The Exclusion Criteria will be: * Cannot provide written informed consent (or assent for the younger students).
Where this trial is running
Hung Hom
- The Hong Kong Polytechnic University — Hung Hom, Hong Kong (Recruiting)
Study contacts
- Principal investigator: Yao Jie Xie, PhD — The Hong Kong Polytechnic University
- Study coordinator: Yao Jie Xie, PhD
- Email: grace.yj.xie@poly.edu.hk
- Phone: 3400 3798
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.